In silico designing of some agonists of toll-like receptor 5 as a novel vaccine adjuvant candidates. - Tayebeh Farhadi; Roman S. Ovchinnikov; Mohammad Mehdi Ranjbar (Netw. Model. Anal. Health Informatics Bioinform., 2016)

Designing and modeling of complex DNA vaccine based on MOMP of Chlamydia trachomatis: an in silico approach. - Tayebeh Farhadi; Mohammad Mehdi Ranjbar (Netw. Model. Anal. Health Informatics Bioinform., 2017)

Immunopeptidome screening to design An immunogenic construct against PRAME positive breast cancer; An in silico study. - Farzaneh Afzali; Zarrin Minuchehr; Samira Jahangiri; Mohammad Mehdi Ranjbar (Comput. Biol. Chem., 2020)

In-silico design of a multi-epitope for developing sero-diagnosis detection of SARS-CoV-2 using spike glycoprotein and nucleocapsid antigens. - Amirreza Javadi Mamaghani; Zahra Arab-Mazar; Siamak Heidarzadeh; Mohammad Mehdi Ranjbar; Shima Molazadeh; Sama Rashidi; Farzad Niazpour; Mohadeseh Naghi Vishteh; Homayoon Bashiri; Arezoo Bozorgomid; Hamed Behniafar; Mohammad Ashrafi (Netw. Model. Anal. Health Informatics Bioinform., 2021)

Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains. - Mona Shafaghi; Zohreh Bahadori; Hamid Madanchi; Mohammad Mehdi Ranjbar; Ali Akbar Shabani; Seyed Fazlollah Mousavi (BMC Bioinform., 2023)

Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development. - Fatemeh Yaghoobizadeh; Mohammad Roayaei Ardakani; Mohammad Mehdi Ranjbar; Mohammad Khosravi; Hamid Galehdari (Comput. Biol. Medicine, 2024)